|
PLEKHF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.45530271061989E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.5847999962636E-08 |
| Normal-vs-Stage2 |
2.12619999999664E-05 |
| Normal-vs-Stage3 |
5.90130000421851E-08 |
| Normal-vs-Stage4 |
1.63810000008979E-07 |
| Stage1-vs-Stage2 |
8.596800E-01 |
| Stage1-vs-Stage3 |
8.809500E-02 |
| Stage1-vs-Stage4 |
3.908000E-02 |
| Stage2-vs-Stage3 |
2.048000E-01 |
| Stage2-vs-Stage4 |
1.394770E-01 |
| Stage3-vs-Stage4 |
8.180800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80349973738703E-10 |
| Normal-vs-AfricanAmerican |
1.55309998195463E-09 |
| Normal-vs-Asian |
4.025600E-02 |
| Caucasian-vs-AfricanAmerican |
6.691800E-01 |
| Caucasian-vs-Asian |
6.402600E-01 |
| AfricanAmerican-vs-Asian |
6.923200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.42450520665716E-11 |
| Normal-vs-Female |
6.85219999629894E-08 |
| Male-vs-Female |
8.307200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.68320000452027E-08 |
| Normal-vs-Extreme_Weight |
9.07290020890628E-10 |
| Normal-vs-Obese |
7.32950000692512E-09 |
| Normal-vs-Extreme_Obese |
2.407900E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.230000E-01 |
| Normal_Weight-vs-Obese |
5.907000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.497800E-01 |
| Extreme_Weight-vs-Obese |
8.116000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.863800E-01 |
| Obese-vs-Extreme_Obese |
7.860400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.51807999999587E-05 |
| Normal-vs-Age(41-60Yrs) |
1.11340003883242E-09 |
| Normal-vs-Age(61-80Yrs) |
1.68780001086333E-09 |
| Normal-vs-Age(81-100Yrs) |
4.155400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.696000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.795200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.205200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.203400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.311400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.526200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.07270012054073E-10 |
| Normal-VS-Type2 PRCC |
5.17089999707565E-08 |
| Normal-VS-KIRP CIMP |
1.6213030917811E-11 |
| Normal-VS-Unclassified PRCC |
4.62349999996725E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.287000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.65304999999449E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.806000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.035530E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.829800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.813400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.71229996637612E-09 |
| Normal-vs-N1 |
1.60330004828069E-09 |
| Normal-vs-N2 |
2.71893618730701E-13 |
| N0-vs-N1 |
2.414600E-01 |
| N0-vs-N2 |
4.07859999995708E-07 |
| N1-vs-N2 |
1.618860E-04 |
|
|
